Cancer immunosurveillance is a process by which an organism's immune system recognizes transformed cells in order to inhibit the growth of neoplastic tissue. It comprises the first phase of immunoediting and is also known as the elimination phase.
- "Immunosurveillance". Nature. Retrieved 9 October 2015.
- Slaney, C. Y.; Rautela, J.; Parker, B. S. (23 September 2013). "The Emerging Role of Immunosurveillance in Dictating Metastatic Spread in Breast Cancer". Cancer Research. 73 (19): 5852–5857. doi:10.1158/0008-5472.CAN-13-1642. PMID 24062312.
- Dunn, Gavin P.; Old, Lloyd J.; Schreiber, Robert D. (August 2004). "The Immunobiology of Cancer Immunosurveillance and Immunoediting". Immunity. 21 (2): 137–148. doi:10.1016/j.immuni.2004.07.017. PMID 15308095.